Gamida Cell Appoints Abigail Jenkins To Succeed Julian Adams As President And CEO

RTTNews | 1073 dagar sedan
Gamida Cell Appoints Abigail Jenkins To Succeed Julian Adams As President And CEO

(RTTNews) - Gamida Cell Ltd. (GMDA) announced Monday that Abigail "Abbey" Jenkins, has joined as President & CEO. Jenkins has also been appointed to Gamida Cell's Board of Directors. Jenkins succeeds Julian Adams, who is retiring in accordance with planned succession and will continue to serve on the company's Board of Directors.

Jenkins brings over 20 years of leadership experience in the biopharmaceutical industry delivering life-enhancing therapies from research to commercialization for patients in need.

Most recently, she served as the Chief Commercial and Business Officer at Lyndra Therapeutics. Prior to Lyndra, she served as Senior Vice President and Business Unit Head of Vaccines at Emergent BioSolutions.

Jenkins also served as Chief Commercial Officer and U.S. Business Head at Aquinox Pharmaceuticals. Additionally, she has held senior commercial and business development positions at Relypsa, Actavis, Pfizer and Medimmune/AZ.

read more
FDA Approves Omisirge Cell Therapy For Blood Cancers

FDA Approves Omisirge Cell Therapy For Blood Cancers

The U.S. Food and Drug Administration approved Gamida Cell Ltd.'s Omisirge (omidubicel-onlv) cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation. Gamida Cell shares gained around 39 percent on Monday's regular trading. The gain continued in the after hours trading with a further growth of 4 percent.
RTTNews | 862 dagar sedan
Euro Falls Amid Political Uncertainty

Euro Falls Amid Political Uncertainty

The euro weakened against other major currencies in the European session on Wednesday, as trader's concern about the collapse of France's government.
RTTNews | 4h 2minuter sedan
Bay Street Likely To Open On Positive Note

Bay Street Likely To Open On Positive Note

Canadian shares are likely to open on a positive note on Wednesday, riding on strong earnings from Royal Bank of Canada and National Bank of Canada. Weak commodity prices and concerns on the geopolitical and tariffs front may weigh limit market's upside.
RTTNews | 4h 27minuter sedan
European Stocks Turning In Mixed Performance

European Stocks Turning In Mixed Performance

European stocks are turning in a mixed performance on Wednesday as political uncertainty in France, and a lack of any significant positive triggers render the mood cautious. Investors are also awaiting earnings updates from AI major NVIDIA.
RTTNews | 4h 54minuter sedan
FTSE 100 Flat In Lackluster Trade; Bank Stocks Drifting Lower

FTSE 100 Flat In Lackluster Trade; Bank Stocks Drifting Lower

U.K. stocks are somewhat subdued in lackluster trade on Wednesday as investors remain a bit reluctant to make significant moves due to a lack of triggers. The benchmark FTSE 100 was at 9,266.25 a little before noon, up 0.45 points over previous close.
RTTNews | 5h 44minuter sedan
CAC 40 Advances After Recent Losses

CAC 40 Advances After Recent Losses

Despite the uncertainty on the political front, the French market is up in positive territory on Wednesday due largely to some bargain hunting at several counters after two successive days of declines. Investors are also looking ahead to AI giant Nvidia's earnings updates.
RTTNews | 5h 58minuter sedan
DAX Remains Weak Despite Paring Some Early Losses

DAX Remains Weak Despite Paring Some Early Losses

German stocks are down in negative territory in cautious trade on Wednesday amid political uncertainty in France ahead of a confidence vote early next month, and anxiety ahead of Nvidia's earnings for clues on the AI trade.
RTTNews | 6h 15minuter sedan
Mixed Sentiment In Asian Markets

Mixed Sentiment In Asian Markets

Asian markets moved in a mixed fashion on Wednesday amidst anxiety ahead of release of earnings update by chip-giant NVIDIA.
RTTNews | 6h 25minuter sedan